‘Potential is huge’: Why Battelle gave its gene therapy startup a head start


Battelle CEO Lou Von Thaer discusses why AmplifyBio will have more impact as a standalone gene and cell therapy company, even after its considerable reach within the Columbus nonprofit.

Click here to read the complete story.

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Originally published May 10, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: